Omega Fund Management, LLC - IMMUNOCORE HLDGS PLC ownership

IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 48 filers reported holding IMMUNOCORE HLDGS PLC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Omega Fund Management, LLC ownership history of IMMUNOCORE HLDGS PLC
ValueSharesWeighting
Q2 2022$1,923,000
+24.8%
51,5350.0%0.61%
+94.9%
Q1 2022$1,541,000
-12.7%
51,5350.0%0.32%
+26.0%
Q4 2021$1,765,000
-7.6%
51,5350.0%0.25%
+16.8%
Q3 2021$1,910,000
-5.1%
51,5350.0%0.21%
-6.1%
Q2 2021$2,012,000
-8.3%
51,5350.0%0.23%
+9.6%
Q1 2021$2,194,00051,5350.21%
Other shareholders
IMMUNOCORE HLDGS PLC shareholders Q3 2021
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 576,923$34,592,30327.53%
RTW INVESTMENTS, LP 6,029,633$361,536,7956.88%
Paradigm Biocapital Advisors LP 1,270,124$76,156,6355.88%
Rock Springs Capital Management LP 3,028,410$181,583,4644.32%
Logos Global Management LP 500,000$29,980,0004.08%
TANG CAPITAL MANAGEMENT LLC 405,600$24,319,7763.58%
GREAT POINT PARTNERS LLC 297,082$17,813,0373.49%
Eschler Asset Management LLP 34,000$2,038,6402.89%
COWEN AND COMPANY, LLC 460,036$27,583,7582.29%
HighVista Strategies LLC 44,094$2,643,8761.21%
View complete list of IMMUNOCORE HLDGS PLC shareholders